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Abstract
Objective—To examine fall risk trajectories occurring naturally in a sample of individuals with 
early to middle stage Parkinson’s disease (PD).
Design—Latent class analysis, specifically growth mixture modeling (GMM) of longitudinal fall 
risk trajectories.
Setting—Not applicable.
Participants—230 community-dwelling PD participants of a longitudinal cohort study who 
attended at least two of five assessments over a two year period.
Interventions—Not applicable.
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Main Outcome Measures—Fall risk trajectory (low, medium or high risk) and stability of fall 
risk trajectory (stable or fluctuating). Fall risk was determined at 6-monthly intervals using a 
simple clinical tool based on fall history, freezing of gait, and gait speed.
Results—The GMM optimally grouped participants into three fall risk trajectories that closely 
mirrored baseline fall risk status (p=.001). The high fall risk trajectory was most common (42.6%) 
and included participants with longer and more severe disease and with higher postural instability 
and gait disability (PIGD) scores than the low and medium risk trajectories (p<.001). Fluctuating 
fall risk (posterior probability <0.8 of belonging to any trajectory) was found in only 22.6% of the 
sample, most commonly among individuals who were transitioning to PIGD predominance.
Conclusions—Regardless of their baseline characteristics, most participants had clear and stable 
fall risk trajectories over two years. Further investigation is required to determine whether 
interventions to improve gait and balance may improve fall risk trajectories in people with PD.
Keywords
Parkinson disease; accidental falls; risk; longitudinal studies; gait
Falls are a disabling and problematic occurrence for people with Parkinson’s disease (PD). 
Falls occur in 45–68% of the PD population annually,1 a rate double that of the general older 
population.2 Falls in people with PD may result in injuries or other adverse consequences, 
which in turn are associated with prolonged hospitalizations and higher healthcare costs.3
Fall risk in PD is multifactorial, with a positive fall history, history of freezing of gait 
(FOG), and reduced gait speed identified as among the most potent predictors of a future 
fall.4 Additionally, the incidence of falls increases with disease progression,1,5 until the 
point at which individuals become relatively immobile and appear to fall less.6 Nevertheless, 
the extent to which fall risk in PD might increase without a concurrent change in the level of 
disease severity, and whether the rate of increase in fall risk might differ according to 
baseline disease severity, remains unclear. It is also unknown whether fall risk fluctuates 
during specific periods of disease progression. These questions are relevant, given mixed 
results about the efficacy of exercise interventions for fall prevention in PD.7–11
Given the progressive neurodegeneration and functional decline associated with PD, 
knowledge about progression of fall risk over time will assist clinicians to more effectively 
prevent and manage falls in this population by helping to improve the manner in which fall 
risk assessment and interventions are employed.1,12 The primary aim of this study, therefore, 
was to track fall risk longitudinally in people with PD. Secondary aims were to investigate 
which characteristics differed between the various fall risk trajectories and the 
characteristics associated with changes in fall risk over time. We hypothesized that over the 
2-year follow up period, most participants classified by a clinical tool at baseline as being at 
high fall risk would remain at high risk, whereas a proportion of those classified by the tool 
as being at low or medium risk would have increased their fall risk. We further hypothesized 
that the postural instability and gait disability (PIGD) subtype of PD would be associated 
with greater progression of fall risk. Individuals with the PIGD subtype have predominantly 
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bilateral and axial symptoms including stooped posture, greater gait and balance 
impairment, and FOG.13
METHODS
Participants
Community-dwelling individuals aged 40 or over, who had been diagnosed with idiopathic 
PD by a neurologist, who were in Hoehn and Yahr stages 1–4, and who had Mini-mental 
State Examination scores ≥24 were eligible for enrolment in a multicentre longitudinal 
cohort study focusing on the natural history of functional decline and quality of life.14 
Exclusion criteria included a diagnosis of atypical parkinsonism or previous surgical 
intervention for PD (e.g. deep brain stimulation).
Participants were assessed “on” medication at baseline and then every six months for a total 
of 24 months. Trained physical therapists assessed participants according to a manual of 
standard operating procedures at one of the following locations: 34 participants at the 
University of Utah, 71 at Boston University, 66 at Washington University in St. Louis, and 
59 at the University of Alabama at Birmingham. Potential predictors and outcomes were 
obtained during each assessment session. Participants continued to receive standard medical 
care over the two-year study period, including neurology follow-ups and other prescribed 
medical or allied health interventions.
This study was approved by the ethics committees of all participating sites. All participants 
provided written informed consent prior to data collection. This study conforms to STROBE 
reporting guidelines.15
Clinical characteristics
Fall risk at each assessment was determined to be low, medium or high based on a 
validated16 simple clinical fall prediction tool. Accordingly, weighted scores were assigned 
for positive fall history in the past year (6 points), positive FOG history in the past month (3 
points), and preferred gait speed <1.1 m/s (2 points). Total scores range from 0–11, with 0 
indicating low, 2–6 indicating medium, and 8–11 indicating high fall risk.4 Falls were 
defined as unintentionally coming to rest on the ground or other lower surface without being 
exposed to overwhelming external force or a major internal event.17 Fall history over the 
past 6-months was collected at each assessment using a forced-choice paradigm: none, once, 
2–10 times, weekly, or daily. History of FOG was determined using Question 3 of the FOG 
Questionnaire,18 i.e. “Do you feel that your feet get glued to the floor while walking, 
making a turn or when trying to initiate walking (freezing)?”; scores ≥1 indicated a positive 
FOG history. Gait speed was determined by averaging the scores from two trials of the 10 
meter walk test, which participants completed at their comfortable pace.
Age, gender, time since PD diagnosis, levodopa equivalent dose19 and PD severity 
according to the motor section (Part 3) of the Movement Disorders Society-sponsored 
version of the Unified Parkinson Disease Rating Scale (MDS-UPDRS)20 were obtained. 
Tremor dominant, PIGD, and indeterminate PD subtypes were determined using relevant 
items of Parts 2 and 3 of the MDS-UPDRS according to published criteria.13 Dyskinesias 
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were quantified using the sum of items in Part 4A of the MDS-UPDRS. Physical activity 
was quantified using the Physical Activity Scale for the Elderly, for which scores range from 
0 to >400 and higher scores indicate higher physical activity levels.21
Data analysis
Latent class analysis, specifically growth mixture modelling (GMM),22 was used to assign 
groups of participants into a small number of distinct trajectories of fall risk based on 
participants’ level of fall risk at each assessment ascertained with the clinical tool. GMM, 
which assumes heterogeneity within a population, obtained the smallest number of latent 
classes (i.e. trajectories) that accounted for all associations between the biannual fall risk 
determinations within the 2-year time period by minimising within-class variation and 
maximising between-class variation.22 This process allowed for the identification of a 
primary fall risk trajectory for each individual and whether individuals were stable within 
their trajectory or fluctuated between trajectories. The posterior probability of belonging to 
each trajectory was obtained for each individual, with participants allocated to the trajectory 
for which the probability was the largest.
The GMM was fitted successively, starting with a one-latent class model that assumed all 
participants had the same progression of fall risk over time. The optimal number of 
trajectories subsequently was determined by examining the Bayesian Information Criterion 
(BIC), the Lo-Mendel-Rubin Likelihood Ratio Test (LMR-LRT) and the Bootstrapped 
Likelihood Ratio Test (BLRT).23 Although participants did not need to have complete data 
(i.e. data for each assessment) to be included in a GMM, we recognized that missing data 
could influence goodness-of-fit tests. Therefore, the first analysis assessed the optimal 
solution with participants having complete data. The analysis was then rerun by including 
participants with data from at least two assessments and compared to those having complete 
data (i.e. from all five assessments). Monte Carlo GMM simulations suggest a sample size 
of 125 is needed for power of 0.86 to reject the hypothesis that the model is misspecified. 
Parameter and standard error estimates at this sample size appear to have little bias.24
Analysis of variance (ANOVA) and chi-square tests were used to describe differences in 
participant characteristics between baseline and the 2-year time point and between the three 
fall risk trajectories. ANOVA and chi-square analyses with statistically significant (p<.05) 
results were followed-up with pair-wise post-hoc comparisons. Bonferroni adjustment was 
used for all post-hoc comparisons. Data examined with ANOVA were scrutinized for 
normality, outliers, and homogeneity of variances. T-tests were used to compare 
characteristics of participants with stable fall risk trajectories (i.e. posterior probabilities 
≥0.8) to those with fluctuating fall risk (posterior probabilities <0.8). MPLUS v6.11 
(Muthen & Muthen, Los Angeles CA) was used to model the GMM and IBM SPSS 
Statistics v22.0 (IBM Corp, Armonk NY) was used for the remaining analyses.
RESULTS
Two hundred and thirty participants with data from at least two assessment points were 
included in the analysis (Table 1). The GMM optimally grouped participants into three fall 
risk trajectories (BIC 1681.33 versus 2093.09 for a one-latent class model, LMR-LRT and 
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BLRT p=.001), which closely mirrored baseline fall risk as determined by the fall prediction 
tool (Figure 1a). Adding a fourth trajectory did not improve model fit from the GMM (BIC 
1688.65, LMR-LRT p=.46 and BLRT p=.48). The fall risk trajectories remained the same 
whether the GMM model included only those participants with complete data (n=124, three-
class model: BIC 1077.4, LMR-LRT and BLRT p<.001, versus four-class model: BIC 
1090.1, LMR-LRT and BLRT p=.76) or those with at least two assessments (Supplemental).
The high fall risk trajectory was the most common (n=98, 42.6%) with 72.4% of these 
individuals identified by the prediction tool as being at high fall risk at baseline. The 
medium fall risk trajectory included 73 participants (31.7%), with 68% identified by the tool 
as being at medium fall risk at baseline. The low fall risk trajectory had 59 participants 
(25.7%), 91.5% of whom were identified by the tool as at low risk at baseline and generally 
remaining low risk at 2-years. The three trajectories were differentiated by their mean fall 
risk with no significant change over time (non-significant slope parameters).
The three components of the clinical fall prediction tool (fall history, gait speed, and FOF 
and PIGD score at baseline significantly differentiated the three fall risk trajectories over 
time (p<.001) (Tables 1 and 2). The fall risk trajectories did not vary by gender (p=.34) or 
age (p=.06). In general, it was easier to identify individuals in the high fall risk trajectory 
than those in the medium and low risk trajectories at baseline. Individuals in the high risk 
trajectory had significantly longer disease duration, increased disease severity based on PD 
motor scores and higher levodopa equivalent doses, greater amounts of dyskinesia and 
reduced physical activity levels than the medium risk trajectories (p<.001). By two years, 
PD motor scores significantly differentiated the three fall risk trajectories (p<.001). In 
contrast, physical activity levels and dyskinesia severity differentiated only high and low 
risk trajectories (p<.001 and p=.046, respectively) but not high and medium risk trajectories 
(p=.09 and p=.23, respectively).
Fifty-two participants (22.6%) demonstrated a fluctuation in fall risk over the two years and 
were identified as having posterior probabilities <0.8 of belonging to any single trajectory 
(Table 3). These individuals appeared to fluctuate primarily between the medium and high 
risk trajectories (Table 2, Figure 1b). These participants had lower PIGD scores and were 
predominantly of tremor dominant or indeterminate motor subtypes at baseline compared to 
participants with stable fall risk trajectories. Shorter PD duration and gait speed reduction of 
0.06 m/s over the first six months were also suggestive of fluctuating fall risk over time (p=.
05–.07).
DISCUSSION
To our knowledge, this is the first study to document the natural, longitudinal fall risk 
trajectories of people with PD. Regardless of their baseline characteristics, most participants 
had clearly identifiable and stable fall risk trajectories over a 2-year period. The distinct 
trajectories, each defined by the presence of either low, medium, or high fall risk at multiple 
time points, provided important support for the idea that fall risk assessment in people with 
PD using a simple clinical tool appears to identify a relatively stable trait, rather than a 
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potentially transient phenomenon vulnerable to influence by fatigue, distraction, general 
health status, or minor changes in disease progression.
We were somewhat surprised by the stability of the trajectories and had expected to see a 
greater incidence of increasing fall risk over two years in individuals with low or medium 
risk at baseline. Indeed, longitudinal studies have demonstrated that fall incidence in people 
with PD increased over time,5,25,26 although the time for increased fall incidence is of long 
duration ranging from 8–11.5 years.5,26 Given the short follow-up of our study, it may be 
that there was insufficient time available for changes in fall history, which is the strongest 
contributor to fall risk,6 FOG history, and preferred gait speed to have occurred.
Our results identified a relatively small group (<25%) of participants with fluctuating fall 
risk trajectories. These participants were mostly identified to be at moderate or high fall risk 
at baseline. Within this group there were individuals whose fall risk constantly fluctuated 
over time, some whose risk appeared to increase over time, and a few whose risk 
surprisingly decreased over time. Changes in fall history and in gait speed between each six-
month time point appeared to be the main contributors to fluctuating fall risk. It is not 
altogether surprising that infrequent fallers who perhaps fall once or twice a year and whose 
fall history changes every six months would demonstrate fluctuating fall risk given that the 
prediction tool is weighted heavily by fall history.4
Gait deterioration has been identified to be strongly associated with falls27,28 and 
disability29 in people with PD, even during early stages of the disease.27,28 PIGD subtype is 
also associated with faster gait deterioration30 and increased fall frequency.26,31 It appeared 
that most individuals with PIGD in our study were already in the high fall risk trajectory. 
The small group of individuals with fluctuating fall risk trajectories generally had lower 
PIGD scores and were of tremor or indeterminate subtypes, indicating there was a potential 
for these individuals to transition towards greater PIGD impairment with further disease 
progression.32–34
Clinical and Research Implications
The combined prevalence (74.3%) of medium and high fall risk trajectories in our sample, 
especially among participants with the PIGD subtype, confirmed that gait and balance 
impairment appears to consistently contribute to falls and fall risk over time in people with 
PD. The result further reinforces the idea that frequent monitoring of gait and balance 
deterioration is a crucial aspect of PD management and rehabilitation.
The stability of most (77.3%) trajectories raises important questions for future clinical 
practice and research. Do stable trajectories simply represent an optimal baseline from 
which to measure the sustained impact of intervention, or could they suggest that sustained 
fall risk reduction may be difficult to achieve? Exercise and physical interventions targeting 
fall risk factors such as FOG, impaired balance and impaired mobility have been shown to 
reduce fall risk in the short-term in some at-risk individuals with PD,35 however the effects 
of such interventions on preventing falls are mixed.7–11 The duration and extent to which 
any reduction in falls and fall risk are sustained following intervention also remain unclear. 
It is likely that interventions to improve gait function in people with PD, particularly in early 
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stages of disease, may also improve fall risk and reduce falls, although the persistence of 
such interventions need to be tested in future randomized trials.
Our results highlight that individuals who present with low PIGD scores at baseline appear 
more likely to have a fluctuating fall risk trajectory compared to those with gait and balance 
impairment, suggesting that a different intervention approach may be required for these 
individuals. These individuals are likely to have shorter disease duration but demonstrate 
deterioration in gait speed over the short term in the absence of marked balance impairment. 
Current management approaches have targeted balance interventions and falls prevention for 
people with moderate to severe disease when such impairments manifest,12,36 yet emerging 
evidence demonstrates that falls are more likely to be prevented in people with less rather 
than more severe disease.7 Early targeting of fall prevention intervention for individuals 
with low baseline PIGD scores, and regular follow up,36 may therefore be efficacious in 
reducing their likelihood of fall risk progression.
Study Limitations
This study had some limitations. First, the relatively small sample size and short follow-up 
period for tracking fall risk trajectories may have skewed the results. Future longitudinal 
studies, particularly those involving inception cohorts at time of PD diagnosis, will require 
longer follow up intervals to better identify changes in fall risk trajectory over time. Second, 
although our study represented a broad distribution of individuals with PD from across the 
USA and is likely to have accounted for much of the variability seen in this population, a 
longer follow-up period may better elucidate the presence or absence of a fluctuating risk 
category. Importantly, GMM assumes heterogeneity exists in the population and that all 
classes are represented. Third, the small number of participants with fluctuating fall risk 
trajectories in our cohort limited our ability to identify factors associated with progression of 
risk that may be remediable with intervention. Although in the minority, identifying these 
individuals is critical to targeting interventions appropriately. Fourth, emerging evidence 
suggests that impaired cognition, particularly in attention, orientation and impulsivity,37–39 
contributes to increased fall risk in people with PD. However, we were unable to determine 
the possible influence of cognitive deterioration on fall risk trajectory, as we did not 
examine cognition in our participants. Finally, we tracked falls via participant recall over six 
months, which may have affected the accuracy of reporting. Nevertheless, participant recall 
is the current standard of care for gathering these data in clinical practice.36
CONCLUSIONS
A large proportion of individuals with PD who are identified to be at high risk of falls will 
fall within the next six months.4,16 Consequently, understanding the rate at which fall risk 
progresses in lower risk individuals and factors associated with such progression will better 
inform the targeting of individualized fall prevention strategies. This study demonstrated 
that fall risk, whether low, medium or high, remained relatively stable over a two-year 
period in most people with mild to moderate PD. Individuals with a high fall risk trajectory 
on average had longer and more severe disease and worse PIGD than individuals with low 
or moderate risk trajectories. Transition to PIGD subtype and deterioration in gait speed 
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over six months were suggestive of fluctuating fall risk over time, highlighting the need for 
intervention to target gait impairments for management of falls and fall risk in people with 
PD.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Fall risk trajectories (A) and stable and fluctuating fall risk trajectories (B) in people with 
PD over a 2-year period according to fall risk scores (low risk: 0, medium risk: 2–6, high 
risk: 8–11) as determined by a simple fall risk prediction tool. Thin lines indicate the 
standard errors surrounding each trajectory.
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